Blog

Maximizing oligonucleotide therapeutic development: How they work

This is the first of three blog posts discussing best practices for developing oligonucleotides. Interest…

Certara2021 年 5 月 7 日

网络研讨会点播

The Wizard of Oligos: There’s no place like having a successful drug development program!

Oligonucleotide therapies— nucleic acid polymers with the potential to treat or manage a wide range…

Certara2021 年 4 月 30 日

On-Demand Webinar

基因疗法治疗罕见病的希望与陷阱

The state of gene therapy faces much uncertainty as recent regulatory and clinical setbacks have…

Certara2021 年 4 月 29 日

Fact Sheet

监管写作

Expert Writing. Faster Approvals. Read our Regulatory Writing Factsheet

Certara2021 年 4 月 28 日

Fact Sheet

匿名化和修订

Certara2021 年 4 月 28 日

Fact Sheet

透明度和披露

Certara delivers expert clinical trial transparency and disclosure services, ensuring compliant global submissions and clear,…

Certara2021 年 4 月 28 日

Fact Sheet

申报审批咨询及相关事务

Certara2021 年 4 月 28 日

Video

Certara (CERT) – Accelerating Medicines with Biosimulation

As seen on CNBC** Certara is the global leader in biosimulation, a powerful and proven…

Certara2021 年 4 月 27 日

Blog

Planning a Health Canada PRCI compliant submission

How to set yourself up for a successful Health Canada PRCI submission

Certara2021 年 4 月 26 日

On-Demand Webinar

第 3 部分：Oligonucleotide therapeutic development: Clinical pharmacology considerations

In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…

Certara2021 年 4 月 21 日

pre-update

Maximizing oligonucleotide therapeutic development: How they work

The Wizard of Oligos: There’s no place like having a successful drug development program!

基因疗法治疗罕见病的希望与陷阱

监管写作

匿名化和修订

透明度和披露

申报审批咨询及相关事务

Certara (CERT) – Accelerating Medicines with Biosimulation

Planning a Health Canada PRCI compliant submission

第 3 部分：Oligonucleotide therapeutic development: Clinical pharmacology considerations

订阅时事通讯

快捷链接

解决方案

联系我们